Treatment may be continued for an additional time period, if needed. Participants who are vaccinated outside of the established sc hedule should return to the or iginal schedule as soon as possible. Table 6.1 defines what constitutes a delayed visit for reasons other than toxicity, whether the participant should continue to be treated, and whether a protocol violation should be reported and recorded. The range of days is counted from the original scheduled date. Table 6.1. Delayed Visit for Re asons Other than Toxicity Treatment Period Range of DaysParticipant TreatmentProtocol Deviation Biopsies Days -14 to 0* Biopsies/Labs Day 0 Vaccine 1, Biopsies** Day 21 (week 3)  2 days Vaccine/Labs No  3 to 7 days Vaccine/Labs Yes  8 or more days Labs Yes Vaccines 2 Day 28 (week 4)  2 days Vaccine/ /Biopsy No  3 to 7 days Vaccine/ /Biopsy Yes  8 or more days Labs Yes Vaccine 3 Day 35 (week 5)  2 days Vaccine/ No NCI Protocol #: CITN-04 Version Date: 27 Jan 2016 39 Treatment Period Range of DaysParticipant TreatmentProtocol Deviation  3 to 7 days Vaccine/ Yes  8 or more days Labs Yes Biopsies** Day 42 (week 6)  2 days Labs No  3 to 7 days Labs Yes  8 or more days Labs Yes Vaccines 4–6 ** Days 56, 77, 98  2 days Vaccine/Labs*** No (weeks 8, 11, 14)  3 to 7 days Vaccine/Labs*** Yes  8 or more days Labs Yes Biopsies (Optional)** Day 112 (Week 16)  7 days Labs No  8 to 14 days Labs Yes  15 or more days Labs Yes Follow-up Week 26  14 days Scans/Labs No  15 days or more Scans/Labs Yes * The pretreatment biopsies should be performed before the first treatment with INCB024360, within 14 days of that start date. For patients with only one or two tumors approachable for biopsy, available tumor blocks from prior biopsies can serve as the pretreatment sample provided at least 20 unstained slides are available. **A participant will be taken of f protocol treatment if more than 1 vaccination is delayed [  3 to 7 days] during the treatment period.